Methods and compositions for treating IgE-related disease using NNT-1 inhibitors
US6849260B2 · kind B2 · utility
0Cited by
5References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 16, 2001 |
| Grant date | Feb 1, 2005 |
| Priority date | — |
| Expiry date | Aug 16, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are novel methods and compositions for treating IgE-related diseases using NNT-1 inhibitors. In one embodiment, the present invention relates to a method of treating IgE-related diseases using a selective binding agent to NNT-1. In another embodiment, the present invention relates to a method of treating IgE-related diseases using an NNT-1 expression modulator. Methods of modulating IgE levels, and of diagnosing, preventing and/or treating certain types of allergic diseases using NNT-1 inhibitors are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.